Status:
RECRUITING
Pancreatic Cancer and Diabetes Mellitus
Lead Sponsor:
Shanghai Changzheng Hospital
Conditions:
Pancreatic Cancer
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are: 1. Are the incident rates of glucose metabolic dis...
Detailed Description
Investigators will prospectively collect data from patients with pancreatic cancer after surgery in participant centers.
Eligibility Criteria
Inclusion
- 1\. male or female Chinese subjects; 2. Age ≥ 18 years; 3. patients with pancreatic cancer who are proposed to undergo pancreatectomy by pancreaticobiliary surgery at our hospital; 4. those who voluntarily completed the Pancreatobiliary Surgery Cohort Study and signed the informed consent; 5. those who have completed and banked serum and pathological specimens at our hospital.
- \-
Exclusion
- 1\. those with a previous history of comorbid diabetes mellitus or pre-diabetes mellitus, or preoperative HbA1C ≥ 6.0% or fasting blood glucose ≥ 6.1 mmol/l; 2. those with positive islet-associated antibodies 3. those with the presence of medications, endocrine disease exposures that can lead to a risk of secondary diabetes; 4. pregnant or nursing women; 5. Cognitive impairment or other reasons for failing to sign the informed consent form.
- \-
Key Trial Info
Start Date :
January 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06585072
Start Date
January 3 2025
End Date
September 1 2026
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changzheng Hospital
Shanghai, Shanghai Municipality, China, 200003